CDC - HAI - Multistate Meningitis Outbreak

CDC - HAI - Multistate Meningitis Outbreak

Multistate Meningitis Outbreak Investigation

CDC Responds to Multistate Meningitis Outbreak
The Centers for Disease Control and Prevention (CDC) with state and local health departments and the Food and Drug Administration (FDA) are investigating a multistate meningitis outbreak of fungal infections among patients who have received a steroid injection of a potentially contaminated product into the spinal area. Several patients suffered strokes that are believed to have resulted from their infection. The investigation also includes fungal infections associated with injections in a peripheral joint space, such as a knee, shoulder or ankle. CDC and public health officials are referring any patients who have symptoms that suggest possible meningitis or a possible peripheral joint infection to their physicians who can evaluate them further. Those patients injected in peripheral joints only are not believed to be at risk for fungal meningitis but could be at risk for joint infection.

See Current Situation Update

This website was last updated October 14, 2012 10:30 AM EDT

At-A-Glance

• Status: Ongoing Investigation
• Infection: Fungal
• Facility Type: Outpatient Setting
• Case Count: 198
• States: 13
• Deaths: 15

Clinician Guidance

• Frequently Asked Questions and Answers
• Health Alert Network
• Guidance

• Case Definitions
• Testing
• Prophylaxis
• MMWR

Patient Guidance

• About the Outbreak
• Patient Guidance
• Fungal Meningitis

• Resources and Links
• Frequently Asked Questions For Patients - Español (Spanish)

News Media

• Digital Press Kit - CDC Responds to Multistate Meningitis OutbreakOctober 13, 2012
• CDC, FDA, Massachusetts Department of Public Health Joint Telebriefing Updating Investigation of Meningitis OutbreakOctober 11, 2012
• Press Release: Update on Nationwide Meningitis OutbreakOctober 5, 2012
• Press briefing transcript: CDC and FDA Joint Telebriefing on Investigation of Meningitis OutbreakOctober 4, 2012

Additional Agencies Involved

• U.S. Food and Drug Administration (FDA)
• Questions and Answers on Fungal Meningitis Outbreak (FDA)
• List of Recalled Products Related to Fungal Meningitis Outbreak (FDA)
• Alert – New England Compounding Center Product Recall Information (Commonwealth of Massachusetts)  [PDF - 24KB]

Current Case Count
View case count map.

Current State Facilities
View facilities map.

What's New on this Website

• NEW: MMWR: Multistate Outbreak of Fungal Infection Associated with Injection of Methylprednisolone Acetate Solution from a Single Compounding Pharmacy — United States, 2012
  October 13, 2012 6:00 PM EDT
• UPDATE: Current Case Count - Multistate Meningitis Outbreak
  October 13, 2012 2:00 PM EDT
• Digital Press Kit - CDC Responds to Multistate Meningitis Outbreak
  October 13, 2012 10:00 AM EDT
• UPDATE: Case Definitions for Meningitis and Septic Arthritis - Multistate Meningitis Outbreak Investigation
  October 12, 2012 3:30 EDT
• NEW: CDC, FDA, Massachusetts Department of Public Health Joint Telebriefing Updating Investigation of Meningitis Outbreak
  October 11, 2012 3:00 PM EDT

More